|
1 Meinhardt U, Mullis PE. The aromatase cytochrome P－450 and its clinical impact. Horm Res(Basel), 2002, 57(5－6): 145－152.
|
|
2 Casper RF, Mitwally MF. Review: Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab, 2006, 91(3): 760－771.
|
|
3 Mauras N, Lima J, Patel D, et al. Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin(exemestane), in young males. J Clin Endocrinol Metab, 2003, 88(12): 5951－5956.
|
|
4 Rosenfeld CR, Roy T, Cox BE. Mechanisms modulating estrogen－induced uterine vasodilation. Vascul Pharmacol, 2002, 38(2): 115－125.
|
|
5 Garcia－Velasco JA, Moreno L, Pacheco A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot study. Fertil Steril, 2005, 84(1): 82－87.
|
|
6 Balasch J, Fábreques F, Penarrubia J, et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor－responder IVF patients with normal basal concentrations of FSH. Hum Reprod, 2006, 21(7): 1884－1893.
|
|
7 Al－Fadhli R, Sylvestre C, Buckett W, et al. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril, 2006, 85(1)：161－164.
|
|
8 Fisher SA, Reid RL, Van Vugt DA, et al. A randomized double－blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril, 2002, 78(2): 280－285.
|
|
9 Cortínez A, De Carvalho ID, Vantman D, et al. Hormonal profile and endometrial morphology in letrozole－controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril, 2005, 83(1)：110－115.
|
|
10 Sammour A, Biljan MM, Tan SL, et al. Prospective randomized trial comparing the effects of letrozole(LE) and clomiphene citrate(CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super－ovulation prior to intrauterine insemination(IUI). Fertil Steril, 2001, 76(Suppl 1)：S110.
|
|
11 Begum MR, Quadir E, Begum A, et al. Role of aromatase inhibitor in ovulation induction in patients with poor response to clomiphene citrate. J Obstet Gynecol Res, 2006, 32(5)：502－506.
|
|
12 Ulkü B, Mustafa B, Sibel K, et al. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: A prospective randomized trial. Fertil Steril, 2006, 86(5)：1447－1451.
|
|
13 Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril, 2001, 75(2)：305－309.
|
|
14 Sohrabvand F, Ansari SH, Bagheri M. Efficacy of combined metformin－letrozole in comparison with metformin－clomiphene citrate in clomiphene－resistant infertile women with polycystic ovarian disease. Hum Reprod, 2006, 21(6)：1432－1435.
|
|
15 Karaer O, Vatansever HS, Oruc S. Implantation: Effect of aromatase inhibitors on implantation. Hum Reprod, 2004, 19(Suppl): i187.
|
|
16 Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod, 2003, 18(8): 1588－1597.
|
|
17 Barroso G, Menocal G, Felix H, et al. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle－stimulating hormone in controlled ovarian hyperstimulation: A prospective, randomized, blinded clinical trial. Fertil Steril, 2006, 86(5)：1428－1431.
|
|
18 Suh CS, Jee BC, Ku SY. Use of aromatase inhibitor(letrozole) combined with gonadotropin in intrauterine insemination cycles. Hum Reprod, 2005, 20(1)：12－13.
|
|
19 Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol, 2005, 192(2)：381－386.
|
|
20 Monnier A. Effects of adjuvant aromatase inhibitor therapy on lipid profiles. Expert Rev Anticancer Ther, 2006, 6(11)：1653－1662.
|
|
21 Tulandi T, Martin J, Al－Fadhi R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril, 2006, 85(6)：1761－1765.
|
|
22 Bedaiwy MA, Formanl R, Mousa NA, et al. Cost－effectiveness of aromatase inhibitor co－treatment for controlled ovarian stimulation. Hum Reprod, 2006, 21(11)：2838－2844.
|